Top

Tag: Pharmaceuticals


Industry, Vaccines

Automation a Key Focus for Moderna’s COVID-19 Vaccine Contractor

September 15, 2020

Via: Genetic Engineering and Biotechnology News

Moderna hired Lonza to make its COVID-19 vaccine in May. Initially, the CDMO will manufacture the vaccine active ingredient—an mRNA molecule in lipid nanoparticles—at plants in the United States and Switzerland. However, the firms plan to establish additional production suites […]


Industry, News, Pharma

Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for BPX-01 and BPX-04

September 15, 2020

Via: BioSpace

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced that it has received a formal notice of allowance from the U.S. Patent […]


Industry, Pharma

Drug Targets Identified More Discerningly

September 1, 2020

Via: Genetic Engineering and Biotechnology News

Experimental drugs face steep odds. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), out of every 5,000 to 10,000 compounds that enter the discovery and development pipeline, just 5 enter clinical trials, and only 1 receives approval. Other […]


Industry, Vaccines

AstraZeneca nets $396M down payment from EU for 300M-plus COVID vaccines

August 28, 2020

Via: FiercePharma

AstraZeneca has been on roll lately, inking COVID-19 vaccine supply deals left and right with countries worldwide. One of its highest-profile pacts—a purchase deal with the European Union—was made official earlier this month, and now, the trading bloc has floated […]


Industry, Vaccines

WHO warns against coronavirus ‘vaccine nationalism and risk of price gouging’

August 13, 2020

Via: CNBC

High demand for a safe and effective vaccine against the coronavirus is already causing competition between countries and could drive prices higher, the World Health Organization’s top official warned Thursday. “When a successful new vaccine is found, there will be […]


Industry, Pharma

Phio Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update

August 12, 2020

Via: BioSpace

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today reported its financial results for the quarter ended June 30, 2020 and provided a business […]


Clinical Trials, Industry, Pharma, Research and Development

Keeping tabs on Covid-19: Cell and gene clinical trials advance despite Covid-19…

August 7, 2020

Via: Pharma IQ

As the pharma industry stands firm in its commitment to advance the sector to fight Covid-19, news has emerged from the European Commission who intend to streamline the development of therapies using genetically modified organisms to treat Covid-19. The governing […]


Pricing, Regulations

Drug Pricing Back in the Spotlight

July 21, 2020

Via: PharmTech

As the world waits anxiously for more effective COVID-19 treatments and for a vaccine to halt the pandemic, analysts on all sides are examining appropriate pricing models for these critical products. Gilead’s $3000 price tag on remdesivir ($2300 for US […]


Industry, Vaccines

Success of Smallpox Vaccine Bears Lessons for Coronavirus Vaccine

July 21, 2020

Via: Drugs.com

Scientists who have identified the early smallpox strains used to create vaccines against the disease say this type of genetic research could help efforts to develop a vaccine against the new coronavirus. Smallpox was among the most dangerous viral diseases […]


Industry, Vaccines

AstraZeneca, U. of Oxford Report Positive Phase I/II Data for COVID-19 Vaccine Candidate

July 20, 2020

Via: Genetic Engineering and Biotechnology News

Researchers from AstraZeneca, the University of Oxford, and its spinout company Vaccitech today published preliminary Phase I/II data showing their closely-watched COVID-19 vaccine candidate AZD1222 (formerly ChAdOx1 nCoV-19) to have an acceptable safety profile, and favorable immunogenicity against the virus. […]


Industry, Pharma

FDA puts Merck’s heart failure drug on priority review track

July 17, 2020

Via: FierceBiotech

The FDA has granted priority review status to Merck’s vericiguat, teeing the Big Pharma to receive an approval decision early next year. Vericiguat, which Merck partnered on with Bayer in a $1 billion deal, will enter the increasingly congested heart […]


News

Relay passes the baton from private to public biotech, making $400M in the process

July 16, 2020

Via: FierceBiotech

Fierce 15 winner Relay Therapeutics has pulled off a major upsized IPO worth $400 million to propel a pipeline of treatments aiming at previously undruggable targets. The $400 million figure is a lucky one for the biotech, given it’s also […]